产品详情
           仅用于工业应用或科学研究,不可用于人类或动物的临床诊断或治疗,非药用.                            Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia